BALYASNY ASSET MANAGEMENT L.P. - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTACW and the CUSIP is 58507N113. A total of 33 filers reported holding MEDTECH ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q1 2023$7,588
+58.9%
95,5100.0%0.00%
Q4 2022$4,776
-20.4%
95,5100.0%0.00%
Q3 2022$6,000
-25.0%
95,5100.0%0.00%
Q2 2022$8,000
-66.7%
95,5100.0%0.00%
Q1 2022$24,000
-52.0%
95,5100.0%0.00%
Q4 2021$50,000
-35.9%
95,5100.0%0.00%
Q3 2021$78,000
-17.9%
95,5100.0%0.00%
Q2 2021$95,000
-9.5%
95,5100.0%0.00%
-100.0%
Q1 2021$105,00095,5100.00%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 500,000$4,923,0000.24%
ANGELO GORDON & CO., L.P. 95,808$943,0000.10%
Radcliffe Capital Management, L.P. 138,194$1,361,0000.03%
Magnetar Financial LLC 1,227,091$103,0000.00%
Kepos Capital LP 145,000$12,0000.00%
MSD Partners, L.P. 133,333$11,0000.00%
CLEAR STREET LLC 242,341$20,0000.00%
Islet Management, LP 163,979$14,0000.00%
KIM, LLC 167,566$14,0000.00%
CastleKnight Management LP 46,371$4,0000.00%
View complete list of MEDTECH ACQUISITION CORP shareholders